Andere Sprachen Lineage Cell Therapeutics, Inc.

Aktien

A2PP89

US53566P1093

LCTX

Realtime-Estimate Cboe BZX Andere Börsenplätze 22:00:17 13.06.2024			% 5 Tage	% 1. Jan.
0,93 ^USD	-1,76 %		-5,13 %	-14,71 %

21.05.	Lineage Cell Therapeutics, Inc. kündigt Aktualisierungen des 2. jährlichen Investorensymposiums für Rückenmarksverletzungen an	CI
09.05.	Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Lineage to Present at 2024 BIO International Convention	30.05.
Lineage Cell Therapeutics : FORM 4 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP CULLEY BRAIN M	29.05.
Lineage Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium	21.05.
Lineage Cell Therapeutics, Inc. Announces Updates to 2nd Annual Spinal Cord Injury Investor Symposium	21.05.
Lineage Cell Therapeutics : Opinion of Sheppard Mullin Richter & Hampton, LLP relating to the legality of the ATM Shares	21.05.
Lineage Cell Therapeutics : Prospectus disclosing information, facts, events	21.05.
Lineage Cell Therapeutics : Immediate Report	11.05.
Lineage Cell: Q1 Earnings Snapshot	09.05.
Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M	09.05.
Lineage Cell Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	09.05.
LINEAGE CELL - OPREGEN PHASE 1/2A CLINICAL STUDY 24-MONTH VISUAL ACUITY RESULTS FEATURED AT 2024 RETINAL CELL AND GENE THERAPY INNOVATION SUMMIT	07.05.
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit	06.05.
Lineage Cell Therapeutics, Inc. Announces 24 Month Visual Acuity Results Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit	06.05.
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024	02.05.
LINEAGE RECEIVES GRANT FROM CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE	01.05.
Lineage Cell Therapeutics : Immediate Report	30.04.
Lineage Cell Therapeutics : Additional proxy soliciting materials - definitive	30.04.
Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY	30.04.
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)	30.04.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Lineage Cell Therapeutics, Inc.

Aktien

A2PP89

US53566P1093

LCTX

Andere Sprachen

Filter